Metformin attenuates salt-induced hypertension in spontaneously hypertensive rats

Hypertension

Volumn 33, Issue 5, 1999, Pages 1135-1140

  Muntzel, Martin S ^a   Hamidou, Ibrahima ^a   Barrett, Shean ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b BRONX COMMUNITY COLLEGE   (United States)

Author keywords

Blood pressure; Heart rate; Metformin; Rats, inbred SHR; Sodium chloride, dietary

Indexed keywords

METFORMIN; SODIUM CHLORIDE;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FLUID INTAKE; HEART RATE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE;

EID: 0032930188     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.5.1135     Document Type: Article

References (34)

1. Bailey CJ, Turner RC. Metformin. New Engl J Med. 1996;334:574-579.
2. Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Int Med. 1991;229:181-187.
3. Giugliano D, Quatraro A, Consoli G, Minei A, Ceriello A, De Rosa N, D'Onofrio F. Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol. 1993;44:107-112.
4. Giugliano D, De Rosa N, Di Maro G, Marfella R, Acampora R, Buoninconti R, D'Onofrio F. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women. Diabetes Care. 1993;16:1387-1390.
5. Chan ACN, Tomlinson B, Critchley JAJ, Cockram CS, Walden RJ. Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients. Diabetes Care. 1993;16: 1035-1038.
6. Calle-Pascual AL, Garcia-Honduvilla J, Martin-Alvarez PJ, Vara E, Calle JR, Munguira ME, Maranes JP. Comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment. Diabete Metab. 1995;21: 256-260.
7. Gudbjörnsdottir S, Friberg P, Elam M, Attvall S, Lönnroth P, Wallin G. The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men. Blood Pressure 1994;3: 394-403.
8. Campbell IW, Duncan C, Patton NW, Broadhead T, Tucker GT, Woods HF. The effect of metformin on glycaemic control, intermediary metabolism and blood pressure in non-insulin-dependent diabetes mellitus. Diabet Med. 1987;4:337-341.
9. Hermann LS, Scherst én B. Bitzen P-O, Kjellström T. Lindgärde F, Melander A. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. Diabetes Care. 1994;17: 1100-1109.
10. Verma S, Bhanot S, McNeill JH. Metformin decreases plasma insulin levels and systolic blood pressure in spontaneously hypertensive rats. Am J Physiol. 1994;267:H1250-H1253.
11. Verma S, Bhanot S, McNeill JH. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats. J Pharmacol Exp Ther. 1994;271:1334-1337.
12. Muntzel MS, Abe A, Petersen JS. Effects of adrenergic, cholinergic, and ganglionic blockade on acute depressor responses to metformin in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1997;281: 618-623.
13. Kosegawa I, Katayama S, Kikuchi C, Kashiwabara H, Negishi K, Ishii J, Inukai K, Oka Y. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance. Hypertens Res. 1996; 19:37-41.
14. Bhalla RC, Toth KF, Tan E, Bhatty RA, Mathias E, Sharma RV. Vascular effects of metformin: possible mechanisms for its antihypertensive action in the spontaneously hypertensive rat. Am J Hypertens. 1996;9:570-576.
15. Haupt E, Knick B, Koschinsky T, Liebermeister H, Schneider I, Hirche H. Oral antidiabetic combination therapy with sulphonylureas and metformin. Diabete Metab. 1991;17:224-231.
16. Sharma RV, Bhalla RC. Metformin attenuates agonist-stimulated calcium transients in vascular smooth muscle cells. Clin Exp Hypertens. 1995;17: 913-929.
17. Peuler JD, Miller JA, Bourghli M, Zammam HY, Soltis EE, Sowers JR. Disparate effects of antidiabetic drugs on arterial contraction. Metabolism. 1997;46:1199-1205.
18. Verma S, Bhanot S, McNeill JH. Decreased vascular reactivity in metformin-treated fructose-hypertensive rats. Metabolism. 1996;45: 1053-1055.
19. Dietz R, Schomig A, Rascher W, Strasser R, Kübler W. Enhanced sympathetic activity caused by salt loading in spontaneously hypertensive rats. Clin Sci. 1980;59:171s-173s.
20. Takata Y, Yamashita Y, Takishita S, Tsuchihashi T, Tomita Y, Kimura Y, Koga T, Fujishima M. Central and peripheral mechanisms of the enhanced hypertension following long-term salt loading in spontaneously hypertensive rats. Jpn Circ J. 1988;52:1317-1322.
21. Winternitz SR, Oparil S. Sodium-neural interactions in the development of spontaneous hypertension. Clin Exp Hypertens. 1982;A4:751-760.
22. Brooks VL. Interactions between angiotensin II and the sympathetic nervous system in the long-term control of arterial pressure. Clin Exp Pharmacol Physiol. 1997;24:83-90.
23. Petersen JS, DiBona GF. Acute sympathoinhibitory actions of metformin in spontaneously hypertensive rats. Hypertension. 1996;27:619-625.
24. Dorella M, Giusto M, Da tos V, Campagnolo M, Palatini P, Rossi G, Ceolotto G, Felice M, Semplicini A, Del Prato S. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistance hypertensive patient with normal glucose tolerance. J Clin Endocrinol Metab. 1996;81: 1568-1574.
25. Marfella R, Acampora R, Verazzo G, Ziccardi P, De Rosa N, Giunta R, Giugliano D. Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients. Diabetes Care. 1996;19:934-939.
26. Lemmer B, Mattes A, Bohm M, Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension. 1993;22:97-101.
27. Andersen D, Haugan K, Sørensen A-M, Christensen S, Petersen JS. Cardiovascular actions of chronic intracerebroventricular administration of metformin in normotensive rats. Pharmacol Toxicol. 1997; 81:7-12.
28. Calhoun DA, Zhu S, Wyss JM, Oparil S. Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats. Hypertension. 1994; 24:1-7.
29. Janssen BJA, Tyssen CM, Struyker-Boudier HAJ. Modification of circadian blood pressure and heart rate variability by five different antihypertensive agents in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1991;17:494-503.
30. DeQuattro V, Lee DD, Allen J, Sirgo M, Plachetka J. Labetalol blunts morning pressor surge in systolic hypertension. Hypertension. 1988; 11(suppl 1):I-198-I-201.
31. Rietbrock N, Woodcock BG. Combined alpha beta blockade and variability in blood pressure. Trends Pharmacol Sci. 1985;6:8-10.
32. Semplicini A, Del Prato S, Giusto M, Campagnolo M, Palatini P, Rossi GP, Valle R, Dorella M, Albertin G. Pessina AC. Short-term effects of metformin on insulin sensitivity and sodium homeostasis in essential hypertensives. J Hypertens. 1993;11(suppl 5):S276-S277.
33. de Costa Lima NK, Lima FB, dos Santos EA, Okamoto MM, Matsushita DH, Hell NS, Heimann JC. Chronic salt overload increases blood pressure without changing insulin sensitivity. Am J Hypertens. 1997;10: 720-727.
34. Reaven GM, Twersky J, Chang H. Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension. 1991;18:630-635.